OTCMKTS:TRUMY

Terumo Stock Forecast, Price & News

$36.31
-0.36 (-0.98 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$36.14
Now: $36.31
$36.89
50-Day Range
$35.19
MA: $37.46
$41.78
52-Week Range
$31.20
Now: $36.31
$44.76
Volume20,222 shs
Average Volume35,427 shs
Market Capitalization$27.58 billion
P/E Ratio35.25
Dividend Yield0.52%
Beta0.38
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.
Terumo logo

Industry, Sector and Symbol

Industry Medical & hospital equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:TRUMY
Previous SymbolNASDAQ:TRUMY
CUSIPN/A
CIKN/A
Phone(133) 374-8111
Employees26,438
Year Founded1964

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.79 billion
Cash Flow$1.48 per share
Book Value$9.14 per share

Profitability

Net Income$783.93 million

Miscellaneous

Market Cap$27.58 billion
Next Earnings Date5/17/2021 (Estimated)
OptionableNot Optionable

Headlines

Terumo Co. (OTCMKTS:TRUMY) Short Interest Update
March 28, 2021 |  americanbankingnews.com
Terumo Enters 100th Anniversary Year
January 5, 2021 |  finance.yahoo.com
India ECB, FCCB and RDB data for August 2020
October 5, 2020 |  in.reuters.com
MicroVention-Terumo Announces New Leadership
September 22, 2020 |  finance.yahoo.com
UV light robot destroys coronavirus in 2 minutes
May 12, 2020 |  finance.yahoo.com
Terumo Corporation (TRUMY)
March 26, 2020 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

0.75 out of 5 stars

Medical Sector

1225th out of 2,016 stocks

Medical & Hospital Equipment Industry

5th out of 7 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$36.31
-0.36 (-0.98 %)
(As of 04/12/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TRUMY News and Ratings via Email

Sign-up to receive the latest news and ratings for TRUMY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Terumo (OTCMKTS:TRUMY) Frequently Asked Questions

Is Terumo a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Terumo in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Terumo stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRUMY, but not buy additional shares or sell existing shares.
View analyst ratings for Terumo
or view top-rated stocks.

What stocks does MarketBeat like better than Terumo?

Wall Street analysts have given Terumo a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Terumo wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Terumo?

Terumo saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 800 shares, a decrease of 55.6% from the February 28th total of 1,800 shares. Based on an average daily volume of 24,000 shares, the short-interest ratio is presently 0.0 days.
View Terumo's Short Interest
.

When is Terumo's next earnings date?

Terumo is scheduled to release its next quarterly earnings announcement on Monday, May 17th 2021.
View our earnings forecast for Terumo
.

How has Terumo's stock price been impacted by COVID-19?

Terumo's stock was trading at $32.71 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TRUMY stock has increased by 11.0% and is now trading at $36.31.
View which stocks have been most impacted by COVID-19
.

Is Terumo a good dividend stock?

Terumo pays an annual dividend of $0.19 per share and currently has a dividend yield of 0.52%. The dividend payout ratio of Terumo is 18.27%. This payout ratio is at a healthy, sustainable level, below 75%.
View Terumo's dividend history.

Who are Terumo's key executives?

Terumo's management team includes the following people:
  • Shinjiro Sato, President, CEO & Representative Director
  • Naoki Muto, Chief Financial & Accounting Officer
  • Kazuhisa Senshu, Chief Clinical & Regulatory Affairs Officer
  • Hiroaki Kasukawa, Chief Technology Officer & Executive Officer
  • Shouji Hatano, Director, Head-Compliance & Legal Affairs

Who are some of Terumo's key competitors?

What is Terumo's stock symbol?

Terumo trades on the OTCMKTS under the ticker symbol "TRUMY."

How do I buy shares of Terumo?

Shares of TRUMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Terumo's stock price today?

One share of TRUMY stock can currently be purchased for approximately $36.31.

How much money does Terumo make?

Terumo has a market capitalization of $27.58 billion and generates $5.79 billion in revenue each year. The company earns $783.93 million in net income (profit) each year or $1.04 on an earnings per share basis.

How many employees does Terumo have?

Terumo employs 26,438 workers across the globe.

When was Terumo founded?

Terumo was founded in 1964.

What is Terumo's official website?

The official website for Terumo is www.terumo.co.jp.

Where are Terumo's headquarters?

Terumo is headquartered at 2-44-1 Hatagaya Shibuya-ku, Tokyo M0, 151-0072.

How can I contact Terumo?

Terumo's mailing address is 2-44-1 Hatagaya Shibuya-ku, Tokyo M0, 151-0072. The company can be reached via phone at (133) 374-8111 or via email at [email protected]


This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.